| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9a0dbd9fcf86a40cb27e8ee6386d4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674b4e31736baeea3215854ff20f63e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d3348147b720beca01a4846325d345 |
| publicationDate |
2010-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2645982-A1 |
| titleOfInvention |
Use of ave5026 for minimizing the incidence of bleedings during an antithrombotic treatment |
| abstract |
The invention relates to the use of AVE5026 for minimizing the incidence of bleedings during an antithrombotic treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013102566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012055844-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013101524-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2446891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012055843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013102565-A1 |
| priorityDate |
2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |